All posts tagged
CAR-T Competition Heats Up with a New IND Approval
A Cure for Cancer? How CAR-T Therapy is Revolutionizing Oncology
Servier offers up to €1.7B for Dual Cancer Checkpoint Inhibitors
French Immunotherapy Partners fight against Autoimmune Disorders
The 10 Biggest Clinical Success Stories of 2016 in European Biotech
Cellectis gets paid for a first Milestone, Investors are pleased
EU approves Combo-Drug for Metastatic Colorectal Cancer
Top 10 Biotech jobs and internships in Europe you MUST see this week! (Pall, Covagen, Novo Nordisk)
First Euronext Biotech IPO of 2016 is Swiss, and for Multiple Sclerosis!
How Good was 2015 for the French Universal CAR-T Biotech?
This Swiss Biotech is Using an Ancient Virus in our Genome to Fight Multiple Sclerosis
Cellectis Full-Steam Ahead with UCART19 Trial for Leukemia in the UK
Labiotech UG, All Rights Reserved -
Send this to friend